Blog
RSS FeedPosted by Michael Wonder on 20 Dec 2016
Proposal to maintain full subsidy for gefitinib (Iressa) from 1 April 2017
20 December 2016 - PHARMAC is seeking feedback on a proposal to amend the contractual terms of funding for gefitinib ...
Posted by Michael Wonder on 18 Dec 2016
Proposal to list a range of orthopaedic implants and associated products supplied by Zimmer Biomet New Zealand
16 December 2016 - PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated ...
Posted by Michael Wonder on 08 Dec 2016
Proposal to amend listings in the National Immunisation Schedule
9 December 2016 - Following a request for proposals for the supply of various vaccines, issued on 15 February 2016, ...
Posted by Michael Wonder on 16 Nov 2016
Proposal to list oral betaine for rare disorder
16 November 2016 - PHARMAC is seeking feedback on a proposal to list betaine (Cystadane) resulting from a provisional agreement ...
Posted by Michael Wonder on 31 Oct 2016
Proposal to list and award sole supply to celecoxib Pfizer
31 October 2016 - Following a request for proposals for the supply of selective cyclooxygenase-2 inhibitors of the ‘coxib’ class ...
Posted by Michael Wonder on 28 Oct 2016
Update on proposed changes to 2nd & 3rd line anti-VEGF treatments for ophthalmic use
28 October 2016 - On 5 September 2016, PHARMAC consulted on a proposal to list ranibizumab (Lucentis) and aflibercept (Eylea) ...
Posted by Michael Wonder on 09 Sep 2016
Proposal relating to two HIV treatments (Tivicay and Kivexa)
9 September 2016 - PHARMAC is seeking feedback on a proposal to list a new treatment for HIV, dolutegravir (Tivicay) and ...
Posted by Michael Wonder on 05 Sep 2016
Proposal related to second & third-line anti-VEGF treatments for ophthalmic use
5 September 2016 - PHARMAC has entered into provisional agreements with Novartis and Bayer and is seeking feedback on a ...
Posted by Michael Wonder on 10 Aug 2016
Proposal to award sole supply of venlafaxine hydrochloride
10 August 2016 - PHARMAC is seeking feedback on a proposal to award sole supply status in the community for venlafaxine hydrochloride ...
Posted by Michael Wonder on 28 Jul 2016
Over 100,000 people set to benefit from PHARMAC vaccines decisions
28 July 2016 - PHARMAC has today announced changes to funded vaccines, which will benefit an extra 100,000 people. ...
Posted by Michael Wonder on 12 Jul 2016
Proposal to award sole supply of metoprolol tartrate injection in the community and DHB hospitals
12 July 2016 - PHARMAC is seeking feedback on a proposal for a sole supply arrangement for Mylan New Zealand Limited’s ...
Posted by Michael Wonder on 12 Jul 2016
Proposal to list new brands of zoledronic acid and vecuronium bromide
12 July 2016 - PHARMAC is seeking feedback on a provisional agreement with Mylan New Zealand Limited for the listing of ...
Posted by Michael Wonder on 07 Jul 2016
Proposal to award sole supply to goserelin acetate (Zoladex) and reference price leuprorelin acetate (Eligard and Lucrin PDS)
7 July 2016 - PHARMAC has entered into a provisional agreement with AstraZeneca. ...
Posted by Michael Wonder on 28 Jun 2016
Cancer patients get another option with PHARMAC eyeing funding for Keytruda
28 June 2016 - Melanoma patients are likely to get a second drug treatment option under a new proposal to provide ...
Posted by Michael Wonder on 28 Jun 2016
Proposal relating to pembrolizumab (Keytruda), nivolumab (Opdivo), posaconazole (Noxafil) and raltegravir (Isentress)
28 June 2016 - PHARMAC recently announced a decision to fund nivolumab (Opdivo) for patients with unresectable or metastatic (stage III ...